Examining issues related to competition in the pharmaceutical marketplace a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.

Similar Items

• Examining issues related to competition in the pharmaceutical marketplace a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
  Published: (2002)
• Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
  Published: (2002)
• Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, June 17, 2003.
  Published: (2003)
• Generic pharmaceutical patent & FDA law
  Published: (2010)
• Generic pharmaceuticals marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
  Published: (2004)